Myriad Genetics Q4 Profit Rises

(RTTNews) - Myriad Genetics Inc. (MYGN) Tuesday reported fourth-quarter net income of $44.1 million or $0.53 per share, compared to $29.1 million or $0.34 per share last year.

On average, 18 analysts polled by Thomson Reuters expected the company to earn $0.44 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues for the quarter grew to $174.1 million from $133.0 million last year. Analysts estimated revenues of $159.87 million for the period.

For the full year 2014, the company expects total revenues of $690 million to $710 million and earnings of $1.87 to $1.94 per share. Analysts currently estimate earnings of $1.86 per share.